Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Filter by last modified time
See new records

Facets

Sort alphabetically | Sort by count

Recent searches

10 Results - per page

IDNameOrganismDiseaseCommentsProper CitationReferenceCategorySexSynonymsVendorCat NumCross ReferencesHierarchyOriginate from Same Individual
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.ICLC Cat# HTL03005, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3ICLCHTL03005BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.NCBI_Iran Cat# C207, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3NCBI_IranC207BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.CLS Cat# 300333/p3803_SK-BR-3, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3CLS300333/p3803_SK-BR-3BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.BCRJ Cat# 0226, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3BCRJ0226BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.IZSLER Cat# BS TCL 156, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3IZSLERBS TCL 156BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.RCB Cat# RCB2132, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3RCBRCB2132BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.KCLB Cat# 30030, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3KCLB30030BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.DSMZ Cat# ACC-736, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3DSMZACC-736BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.ATCC Cat# HTB-30, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3ATCCHTB-30BTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
CVCL_0033SK-BR-3Homo sapiensBreast adenocarcinomaPart of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808. Doubling time: ~2-3 days (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Exosome proteome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: SKBR3B; In PubMed=26378940. Discontinued: RCB; RCB2132. Derived from metastatic site: Pleural effusion.KCB Cat# KCB 200723YJ, RRID:CVCL_0033References (30)Cancer cell lineFemaleSK-Br-3, Sk-Br-3, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3KCBKCB 200723YJBTO; BTO:0002419 CLO; CLO_0009034 EFO; EFO_0001236 MCCL; MCC:0000424 CLDB; cl4310 CLDB; cl7143 AddexBio; C0006007/65 ATCC; HTB-30 BCRJ; 0226 BioSample; SAMN01821597 BioSample; SAMN03471462 CCLE; SKBR3_BREAST CCRID; 3111C0001CCC000085 CCRID; 3131C0001000700049 ChEMBL-Cells; CHEMBL3308062 ChEMBL-Targets; CHEMBL613834 CLS; 300333/p3803_SK-BR-3 Cosmic; 687499 Cosmic; 755294 Cosmic; 759896 Cosmic; 871159 Cosmic; 894090 Cosmic; 897742 Cosmic; 904385 Cosmic; 921974 Cosmic; 923062 Cosmic; 934531 Cosmic; 944297 Cosmic; 979713 Cosmic; 991329 Cosmic; 997935 Cosmic; 1000127 Cosmic; 1010922 Cosmic; 1018478 Cosmic; 1044209 Cosmic; 1046958 Cosmic; 1129655 Cosmic; 1136357 Cosmic; 1176645 Cosmic; 1287914 Cosmic; 1289405 Cosmic; 1308997 Cosmic; 1434957 Cosmic; 1524342 Cosmic; 1571789 Cosmic; 1609462 Cosmic; 2036669 Cosmic; 2165013 Cosmic; 2301535 Cosmic; 2318379 Cosmic; 2361351 DSMZ; ACC-736 GEO; GSM69195 GEO; GSM73742 GEO; GSM115115 GEO; GSM149978 GEO; GSM149986 GEO; GSM149994 GEO; GSM152556 GEO; GSM152557 GEO; GSM152558 GEO; GSM152559 GEO; GSM154096 GEO; GSM154097 GEO; GSM154098 GEO; GSM154099 GEO; GSM154100 GEO; GSM154101 GEO; GSM154102 GEO; GSM154104 GEO; GSM154107 GEO; GSM155215 GEO; GSM170624 GEO; GSM170625 GEO; GSM170626 GEO; GSM170627 GEO; GSM170630 GEO; GSM170631 GEO; GSM170633 GEO; GSM170634 GEO; GSM183440 GEO; GSM183441 GEO; GSM186457 GEO; GSM186458 GEO; GSM217596 GEO; GSM274644 GEO; GSM274663 GEO; GSM344357 GEO; GSM344407 GEO; GSM350501 GEO; GSM378146 GEO; GSM481334 GEO; GSM590106 GEO; GSM595617 GEO; GSM783927 GEO; GSM827582 GEO; GSM845399 GEO; GSM847432 GEO; GSM847499 GEO; GSM844686 GEO; GSM844687 GEO; GSM887575 GEO; GSM888658 GEO; GSM1008913 GEO; GSM1038850 GEO; GSM1038851 GEO; GSM1038852 GEO; GSM1038853 GEO; GSM1038854 GEO; GSM1053720 GEO; GSM1172989 GEO; GSM1172895 GEO; GSM1214572 GEO; GSM1264069 GEO; GSM1264074 GEO; GSM1264111 GEO; GSM1264116 GEO; GSM1374872 GEO; GSM1374873 GEO; GSM1374874 GEO; GSM1401659 GEO; GSM1661988 GEO; GSM1833627 ICLC; HTL03005 IMGT/HLA; 12368 IZSLER; BS TCL 156 KCB; KCB 200723YJ KCLB; 30030 LINCS_HMS; 50057 LINCS_LDP; LCL-1475 Lonza; 70 NCBI_Iran; C207 PRIDE; PXD000691 PRIDE; PXD002053 PRIDE; PXD002057 PRIDE; PXD002281 PRIDE; PXD002486 RCB; RCB2132 TOKU-E; 3129 Wikidata; Q7390592CVCL_1074 ! AU565
X
  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.